| Market Size in 2022 | Market Forecast in 2030 | Growth Rate (in %) | Base Year |
|---|---|---|---|
| USD 1,680.70 Million | USD 3,608.90 Million | CAGR at 10.02% | 2022 |
According to the report published by Zion Market Research, the global Cardiac Point-of-Care (POC) Market size was valued at USD 1,680.70 Million in 2022 and is predicted to reach USD 3,608.90 Million by the end of 2030. The market is expected to grow with a CAGR of 10.02% during the forecast period. The report analyzes the global Cardiac Point-of-Care (POC) Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Cardiac Point-of-Care (POC) Market industry.
Cardiac POC is a type of blood test which also includes testing of the cholesterol and coagulation. Cardiac POC helps in the detection of the enzyme that is released if a person is suffering from critical cardiac illness. Enzymes can be lactate, brain natriuretic peptides, troponin, and dehydrogenase isoenzymes. Cardiac POCs are also helpful in detecting other conditions such as angina and myocardial infarction. The cardiac POC provides precise information about the markers that are released when the heart fails. Owing to the test the turnaround time minimizes thus helping in early diagnosis.
Some of the factors that are driving the growth of the cardiac point-of-care (POC) market are the growing numbers of the cardiac patients and the increasing requirement to diagnose these diseases. Moreover, the decrease in the turnaround time and availability of the technically advanced products having enhanced characteristics such as automation and miniaturization is also propelling the growth of the market.
Factors that are limiting the growth of the cardiac point-of-care (POC) market are a financial downturn and the concerns regarding reimbursement. One of the challenges faced by the market is the lack of precise actions in detecting the existence of the cardiovascular diseases.
The introduction of the novel products, mergers and acquisitions by the market players, and the increasing diagnostic facilities are some of the trends that are positively affecting the growth of the market.
| Report Attributes | Report Details |
|---|---|
| Report Name | Cardiac Point-of-Care (POC) Market Research Report |
| Market Size in 2022 | USD 1,680.70 Million |
| Market Forecast in 2030 | USD 3,608.90 Million |
| Growth Rate | CAGR of 10.02% |
| Number of Pages | 180 |
| Key Companies Covered | Alere Inc., Boston Scientific Corp., Abbott Laboratories, Roche Diagnostics, and Medtronic Inc., among others. |
| Segments Covered | By Device Type, By further sub-divided, By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2022 |
| Historical Year | 2017 - 2021 |
| Forecast Year | 2023 - 2030 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The cardiac point-of-care (POC) market is segmented based on the device type.
On the basis of the device type, the market is segregated into cardiac POC testing analyzer and cardiac POC test kits. The cardiac POC test kits are further sub-divided into biomarker test, myoglobin biomarker test, myoglobin biomarker test, cardiac troponin biomarker test, hybrid test, creatine kinase-myoglobin (CK-MB), and brain natriuretic peptide (BNP) test.
North America is dominating the cardiac point-of-care (POC) market which is followed by Europe. The major factors that are driving the market are the growing demand for the home healthcare, increased number of cardiac patients, and the favorable government policies. Other factors that are positively influencing the market growth are favorable healthcare reforms, early adoption of the advanced technologies, advanced healthcare infrastructure, a wide range of upgradation in the Clinical Laboratory Improvement Amendments (CLIA) waved measures and the increased health awareness among the patients. The cardiac point-of-care (POC) market in Europe is positively affected due to the increased occurrences of chronic ailments, improved focus in the advancement of the connected healthcare, and the growing demand for the POC testing devices.
The cardiac point-of-care (POC) market in the Asia Pacific is expected to develop at a rapid rate in the coming years owing to the increasing healthcare spending and the growing awareness about the diagnostic treatments.
Some of the most important market players in the cardiac point-of-care (POC) market include :
By Device Type
By Further Sub-Divided
By Region
FrequentlyAsked Questions
Cardiac Point-of-Care (POC) refers to rapid diagnostic testing performed near the patient to detect cardiac biomarkers. It enables quick diagnosis and timely management of heart-related conditions.
The global cardiac point-of-care (POC) market is expected to be driven by the rising cardiovascular disease prevalence, demand for rapid diagnostics, and increasing use of bedside and emergency testing.
According to study, the global cardiac point-of-care (POC) market size was worth around USD 1,680.70 Million in 2022 and is predicted to grow to around USD 3,608.90 Million by 2030.
The global cardiac point-of-care (POC) market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 10.02% during the forecast period from 2023-2030.
The global cardiac point-of-care (POC) industry is projected to be challenged by Challenges include strict clinical validation, accuracy requirements, and regulatory approvals. Reimbursement uncertainty and integration into emergency workflows affect adoption rates.
The Opportunities include rapid diagnostics in emergency and remote settings, decentralized healthcare, and integration with digital health platforms. Aging populations drive demand will offer significant growth opportunities in the cardiac point-of-care (POC) market.
AI-assisted cardiac biomarker detection; microfluidic & lab-on-chip platforms; connectivity to EMR for fast triage are the emerging trends and innovations impacting the cardiac point-of-care (POC) market.
The global cardiac point-of-care (POC) market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global cardiac point-of-care (POC) market are; Alere Inc., Boston Scientific Corp., Abbott Laboratories, Roche Diagnostics, and Medtronic Inc., among others. and others.
The report explores crucial aspects of the cardiac point-of-care (POC) market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients